TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: proportion prescribing for any RTD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative satisfaction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores of back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 or higher Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Median apnea-hypopnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Verbal Comprehension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuronal responses to language task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean cord blood pH levels at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Apgar scores at 1 minute and 5 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of first malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of first malaria with symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Numerical Rating Scale pain score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean energy content of discretionary foods packed in lunchboxes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median relative decrease in MRI-PDFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Declines in MRI-PDFF of ≥30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of attendance at mental health institution
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bile levels of cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bile levels of endotoxins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Follow-up rate of patients at 24 weeks
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum levels of TNF‐α and IL‐8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Modified medical research council (mMRC) dyspnea scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: average production of upland rice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advisory limits for contaminants exceeded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative scar area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Observer's overall opinion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient's overall opinion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of BPD or death
Endpoint domain: Mortality/survival
Primary endpoint: SPPB performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent diabetes-specific functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Participation in structured diabetes education
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Intervention session attendance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance use and IPA perpetration status
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of OAB wet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: GRA scale changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Drug delivery in COPD subjects at hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disciplinary referrals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: TAPSE measurement for prediction of low-risk AHF patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of time in the target RASS range without rescue sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life-space mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: dislodging force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mature oocyte rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of worsening symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progress in behavioural change stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative doses of beta-blockers and ACE inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of outpatient visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Antibody responses to all antigens except Hib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pre-booster antibody persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Booster response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: tacrolimus total daily dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tacrolimus trough levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a new allegation within 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: alar flaring mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alar base mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety state improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvements in anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in participants' attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in participants' stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in participants' knowledge and confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intact FGF21 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of knowledge about ergonomics
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Numerical Rating Scale (NRS) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in waiting time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total platelets used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Persistent bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Fatty liver grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Cumulative time with a BIS under 40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: VMO muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isometric strength (VMO and GL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's dependence for adapted activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Caregiver's subjective burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Postpartum bonding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HADS scores improvement at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trust in AI diagnosis of cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort with automated robotic surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to pay for AI review of medical imaging
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of Agent DCB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of Agent DCB
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement between DLS-derived HR and ECG-derived HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preparation time per attachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attachment damage rates
Endpoint domain: Adverse events/effects
Primary endpoint: Total coliform count (cfu/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month smoking cessation outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMI rates
Endpoint domain: Mortality/survival
Primary endpoint: Total treatment effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation Scoring System scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of cycles performed per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients COVID-19 negative by RT-PCR on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in visceral fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increment of leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: excess arm volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional improvement percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean primary end point-free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of clinical sepsis within three days of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: better outcome in the presence of clinical‐ASPECTS mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MetS risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to perform regional anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of head movements during procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attempts to perform regional anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiological response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appropriate antibiotic prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UTI-related hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: antibiotic prescriptions per 1000 resident-care days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Probing Depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mean systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CV of systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adjusted SD of PR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adolescent motor outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adolescent behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sustained VT/VF
Endpoint domain: Mortality/survival
Primary endpoint: HGS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: theta/beta power ratio (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: premenstrual symptoms of confusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: premenstrual symptoms of headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: premenstrual symptoms of nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps cross‐sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: maximum knee‐extensor force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to first feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Relative risk of pocket closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported physical activity and muscle strengthening activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mothers' acceptance of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mothers' breastfeeding self-efficacy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in fathers' attitude towards breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative nausea/vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (Area Under the Curve) for predictive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usefulness of CET for diagnosis and treatment support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median postoperative COMI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TCS ≤1 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chewing pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OHRQoL scores (OHIP-14)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: anterior and posteromedial stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: posterolateral stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Chair stand time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of fall-related fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first outdoor fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates at 6 months and 12 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Seizure-freedom rates maintained for at least 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of T2D
Endpoint domain: Mortality/survival
Primary endpoint: improved mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in android-to-gynoid fat ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decrease in total fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CSBM (Complete Spontaneous Bowel Movements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in BSFS (Bristol Stool Form Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinically significant improvement in EPDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PPD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No longer have symptoms consistent with current MDD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional abuse awareness levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of HPV virus-like particles
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in AISRS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance and gait velocity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in level of consciousness (GCS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Levels of IL-1, IL-6, and PGE-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: stroke awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stroke probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically relevant scale scores (MAS, UWDRS, BFM, ADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary NMRT/F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NMRF/F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NMRT/T
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in histological features of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Node negative rate by pathology after NAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQoL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FADI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with treatment effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interagency communications and services provided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in depression symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in working memory and processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma drug concentration-time curve over 24 h (AUC0–24h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration at 24 h post-dose (C24h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of ball flight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal break
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical break
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBD-Control improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resilience change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: progression-free survival time
Endpoint domain: Mortality/survival
Primary endpoint: dosimetry penalty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hypoxia events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Detection rate of pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔSDLP value for the difference between BAC levels of 0 and 0.05%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls with adverse outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Complete expulsion of the fetus and placenta within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Median time from misoprostol induction to fetal expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Expulsion of the fetus within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Corrected calcium (Ca2+) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: average e′ velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lateral e′ velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes